Sign in
4

Changes in Ownership

Cue Biopharma, Inc. Filed Acc 0001209191-22-021449

Options or other derivatives

  • CHIEF EXECUTIVE OFFICER acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

PASSERI DANIEL R · CHIEF EXECUTIVE OFFICER

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-25 Grant or award : show line 1 in the form Stock Option (right to buy) +100,000 100,000 D
Loading xslF345X03/doc4.xml…